Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Meeting Updates
Outcome of Board Meeting and Compliances of Regulation 30 of SEBI LODR, 2015.09-04-2024
09-04-2024
Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., April 09, 2024, inter alia, considered and approved investing Company funds by way of infusing initial capital of Rs. 50,000/- i.e., holds 50% stake in proposed partnership firm having the same business segment i.e., pharmaceutical segment.09-04-2024
Medico Intercontinental Ltd - 539938 - Compliances - PCS Certificate As On 31.03.2024
Submission of Compliance Certificate pursuant to Reg. 40(9) of SEBI LODR, 2015 issued by PCS for the financial year ended 31.03.2024.08-04-2024
Medico Intercontinental Ltd - 539938 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMedico Intercontinental Ltd 2CIN NO.L24100GJ1984PLC111413 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 3.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PUNEETA SHARMA Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: mail@medicointercontinental.com Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH Designation: CHIEF FINANCIAL OFFICER EmailId: mail@medicointercontinental.com Date: 03/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.03-04-2024
Medico Intercontinental Ltd - 539938 - Compliances - Compliance Certificate For The Year Ended 31 March, 2024
Compliance Certificate for the year ended 31 March, 202403-04-2024
Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.03-04-2024
Medico Intercontinental Ltd - 539938 - Closure of Trading Window
Intimation of Closure of Trading Window for Designated persons and immediate relative of Designated Persons.30-03-2024
Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR) - Newspaper Publication15-02-2024
Medico Intercontinental Ltd - 539938 - Results - Financial Results For The Quarter And Nine Months Ended 31/12/2023.
Results - Financials for the Quarter and nine months ended 31/12/202314-02-2024
Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2024, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2023 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results along with Limited Review Report' for the quarter and nine months ended on December 31, 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com. The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:55 PM.14-02-2024